CHLOROTHIAZIDE SODIUM

Post-LOE

chlorothiazide sodium

Sagent Pharmaceuticals

ANDAINJECTIONINJECTABLE

Approved

Jun 2014

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

CHLOROTHIAZIDE SODIUM (chlorothiazide sodium) by Sagent Pharmaceuticals is clinical pharmacology: the mechanism of the antihypertensive effect of thiazides is unknown. Approved for pregnancy, just, heart failure and 2 more indications. First approved in 2014.

Drug data last refreshed 20h ago

Mechanism of Action

CLINICAL PHARMACOLOGY: The mechanism of the antihypertensive effect of thiazides is unknown. Chlorothiazide does not usually affect normal blood pressure. Chlorothiazide affects the distal renal tubular mechanism of electrolyte reabsorption. At maximal therapeutic dosage all thiazides are…

Indications (5)

pregnancy

Worked on CHLOROTHIAZIDE SODIUM at Sagent Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.